Guoqing Q. Zang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
The outbreak of seasonal influenza after the COVID-19 pandemic in China: Unraveling the "Immunity debt".
Journal: Infectious diseases now
Published: September 25, 2023
Co-circulation and co-infection of COVID-19 and influenza in China: challenges and implications.
Journal: Frontiers in public health
Published: September 17, 2023
Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism.
Journal: Antiviral research
Published: February 25, 2023
Role of Autophagy in the Ubiquitinated Hepatitis B Virus Core Antigen Enhancing Dendritic Cell Function.
Journal: Viral immunology
Published: October 31, 2022
Exosomes loading Tapasin enhance T cell immune response by autophagy to inhibit HBV replication.
Journal: Journal of medical virology
Published: June 24, 2022
Evaluation of the metagenomic next-generation sequencing performance in pathogenic detection in patients with spinal infection.
Journal: Frontiers in cellular and infection microbiology
Published: June 13, 2022
Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis.
Journal: Journal of gastrointestinal oncology
Published: March 31, 2022
Ubiquitinated Hepatitis D Antigen-Loaded Microvesicles Induce a Potent Specific Cellular Immune Response to Inhibit HDV Replication in Vivo.
Journal: Microbiology spectrum
Published: December 15, 2021
Advances in 3D cell culture for liver preclinical studies.
Journal: Acta biochimica et biophysica Sinica
Published: December 27, 2020
Molecular epidemiology and clinical characteristics of hepatitis delta virus (HDV) infected patients with elevated transaminases in Shanghai, China.
Journal: BMC infectious diseases
Published: December 12, 2019
Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
Journal: Drug design, development and therapy
Published: January 08, 2019
Last Updated: 09/26/2026